Statement re ECO Animal Health and University of Georgia sign second poultry vaccine development licencing deal
Monday, February 11, 2019 11:17 AM

ECO Animal Health Group plc


ECO Animal Health and University of Georgia sign second poultry vaccine development licencing deal

ECO Animal Health Ltd (ECO), a wholly owned subsidiary of ECO Animal Health Group plc, is pleased to announce that it has entered a second worldwide exclusive licensing deal with the Poultry Diagnostic & Research Center, College of Veterinary Medicine at the University of Georgia (UGA).

This deal, which follows on from the one leading to the development of potential vaccines in the field of Mycoplasma gallisepticum, allows ECO to further develop, register and commercialize a live attenuated Mycoplasma synoviae vaccine for poultry developed by UGA. University researchers have concluded preliminary proof of concept efficacy and safety studies with this vaccine.

Peter Lawrence, Non-Executive Chairman of ECO Animal Health Group plc said, “Mycoplasma synoviae is a bacterium thataffects predominately commercial layers and breeding birds worldwide resulting in a 5 to 10 per cent loss in egg production and lower egg quality in affected flocks “.

UGA Professor Naola Ferguson-Noel, a researcher in the Poultry Diagnostic & Research Center said, “We look forward to working with ECO Animal Health to help further develop this Mycoplasma synoviae vaccine into an approved product”.

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.


About ECO Animal Health Ltd

ECO Animal Health based in London U.K. is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets. Its products for these growth markets promote well-being in animals and include the novel antimicrobial, Aivlosin®, as well as a range of generic therapeutic products.

About University of Georgia

UGA is an American public, flagship, and comprehensive research university based in Athens, Georgia. It has been ranked in the Top 10 of all USA universities for licensing deals for the past decade and, to date, more than 700 UGA products and technologies have been introduced to the marketplace.